Literature DB >> 12186574

Two new empirically derived reasons to use the assessment of basic learning abilities.

David F Richards1, W Larry Williams, William C Follette.   

Abstract

The Assessment of Basic Learning Abilities (ABLA) comprises six levels of hierarchically ordered visual and auditory-visual discriminations. Scores on the ABLA, Vineland Adaptive Behavior Scales, and the Wechsler Intelligence Scale-Revised were obtained for 30 participants selected using a stratified random sample (i.e., by level of mental retardation) from 499 people served by a state center. Two noteworthy findings were (a) that correlations between the Vineland domains and the ABLA were all significant and ranged between .65 and .73, and (b) no participant performing below ABLA Level 6 was testable on the WAIS-R. Thus, Level 6 can be used as an efficient screen to determine the testability of this population on standardized intelligence tests. Implications for practitioners are discussed.

Entities:  

Mesh:

Year:  2002        PMID: 12186574     DOI: 10.1352/0895-8017(2002)107<0329:TNEDRT>2.0.CO;2

Source DB:  PubMed          Journal:  Am J Ment Retard        ISSN: 0895-8017


  3 in total

1.  The hierarchical relationship between several visual and auditory discriminations and three verbal operants among individuals with developmental disabilities.

Authors:  Carole Marion; Tricia Vause; Shayla Harapiak; Garry L Martin; C T Yu; Gina Sakko; Kerri L Walters
Journal:  Anal Verbal Behav       Date:  2003

2.  Predicting the relative efficacy of verbal, pictorial, and tangible stimuli for assessing preferences of leisure activities.

Authors:  Cecile de Vries; C T Yu; Gina Sakko; Kirsten M Wirth; Kerri L Walters; Carole Marion; Garry L Martin
Journal:  Am J Ment Retard       Date:  2005-03

3.  Predicting Optimal Preference Assessment Methods for Individuals with Developmental Disabilities.

Authors:  Kendra M Thomson; Diana Czarnecki; Toby L Martin; C T Yu; Garry L Martin
Journal:  Educ Train Dev Disabil       Date:  2007-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.